Cellebrite DI (CLBT) Gains from Investment Securities (2021 - 2024)

Cellebrite DI has reported Gains from Investment Securities for 4 years, with the latest figure at $120.0 million in Q3 2024.

• On a quarterly basis, Gains from Investment Securities rose 5742.65% year-over-year to $120.0 million in Q3 2024; TTM through Dec 2024 was $173.1 million, a 389.74% increase from a year earlier, with the FY2024 full-year figure at $173.1 million, up 211.63% from the prior year.
• Gains from Investment Securities was $120.0 million for Q3 2024 at Cellebrite DI, up from $12.7 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $120.0 million in Q3 2024, with the low at -$17.1 million in Q1 2022.
• Average Gains from Investment Securities over 4 years is $12.3 million, with a median of $3.5 million recorded in 2021.
• The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities slumped 264.37% in 2022, then surged 5742.65% in 2024.
• Over 4 years, Gains from Investment Securities stood at -$15.5 million in 2021, then surged by 102.42% to $375000.0 in 2022, then surged by 2509.33% to $9.8 million in 2023, then soared by 1126.45% to $120.0 million in 2024.
• The last three Gains from Investment Securities figures came in at $120.0 million (Q3 2024), $12.7 million (Q2 2024), and $40.4 million (Q1 2024), per Business Quant data.